Grand Central Oyster Bar Closes After Briefly Opening at Limited Capacity

Less than two weeks after it reopened for indoor dining, the Grand Central Oyster Bar, one of New York City’s most famed restaurants, has closed its doors again—at least for the time being.

Officials with the dining spot, a fixture in Grand Central Terminal since the railway hub’s opening in 1913, said business was too slow at this point, defying their hopes and expectations. The restaurant, which shut down in mid-March because of the coronavirus pandemic, restarted operations when New York state allowed indoor dining to resume within the five boroughs on Sept. 30.

Oyster Bar officials said they knew it was never going to be an easy ride, given that the state had limited indoor dining to 25% capacity. But Executive Chef Sandy Ingber said the restaurant was still unable to fill tables to anywhere near that level in the short period since it had started again, with sales

Read More

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mesoblast Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES–(BUSINESS WIRE)–The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Mesoblast Limited (“Mesoblast” or “the Company”) (NASDAQ: MESO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s securities between April 16, 2019 and October 1, 2020, inclusive (the ”Class Period”), are encouraged to contact the firm before December 7, 2020.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected]

The class, in this case,

Read More

Get Access to Kim Perell’s Side Hustle Accelerator for Just $30 for a Limited Time

With the world economy sputtering and businesses closing all over the country, you may not think right now is a good time to start a business. But it is a good time to start a side hustle. With the flexibility of remote work, companies are looking for innovative ways to save money and recruit the best talent, making contracts and consulting work more in-demand. Regardless of your skills, Kim Perell’s Side Hustle Accelerator Course will help you start earning some extra income as soon as possible.



a woman standing in front of a computer screen


© Kim Perell


Kim Perell is an award-winning entrepreneur, investor, and bestselling author who has been an early-stage investor in more than 80 startups, 16 of which were acquired by Fortune 500 companies. She’s been featured on CNBC, Fox Business, MSNBC, and hosted Good Morning America’s Side Hustle Showdown. Perell regularly appears as a judge on Entrepreneur’s Elevator Pitch series.

Loading...

Load Error

This

Read More

The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Mesoblast Limited (MESO)

The Law Offices of Frank R. Cruz announces that it has filed a class action lawsuit in the United States District Court for the Southern District of New York, captioned Kristal v. Mesoblast Limited, et al., (Case No. 1:20-cv-08430), on behalf of persons and entities that purchased or otherwise acquired Mesoblast Limited (“Mesoblast” or the “Company”) (NASDAQ: MESO) securities between April 16, 2019 and October 1, 2020, inclusive (the “Class Period”). Plaintiff pursues under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”)

If you are a shareholder who suffered a loss, click here to participate.

Mesoblast develops allogeneic cellular medicines using its proprietary mesenchymal lineage cell therapy platform. Its lead product candidate, RYONCIL (remestemcel-L), is an investigational therapy comprising mesenchymal stem cells derived from bone marrow. In February 2018, the Company announced that remestemcel-L met its primary endpoint in a Phase 3 trial

Read More

Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Mesoblast Limited

Glancy Prongay & Murray LLP (“GPM”) announces that it has filed a class action lawsuit in the United States District Court for the Southern District of New York, captioned Kristal v. Mesoblast Limited, et al., (Case No. 1:20-cv-08430), on behalf of persons and entities that purchased or otherwise acquired Mesoblast Limited (“Mesoblast” or the “Company”) (NASDAQ: MESO) securities between April 16, 2019 and October 1, 2020, inclusive (the “Class Period”). Plaintiff pursues under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”)

Investors are hereby notified that they have 60 days from the date of this notice to move the Court to serve as lead plaintiff in this action.

If you suffered a loss on your Mesoblast investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at https://www.glancylaw.com/cases/mesoblast-limited/.

Read More

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Pintec Technology Holdings Limited (PT)

LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming November 30, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Pintec Technology Holdings Limited (“Pintec” or the “Company”) (NASDAQ: PT) securities pursuant and/or traceable to Pintec’s October 2018 initial public offering (“IPO” or the “Offering”).

If you suffered a loss on your Pintec investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at https://www.glancylaw.com/cases/pintec-technology-holdings-limited/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

In October 2018, Pintec completed its IPO in which it sold more than 3.7 million American Depositary Shares (“ADSs” or “shares”) at $11.88 per share.

On

Read More

DEADLINE REMINDER: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Golar LNG Limited (GLNG)

BENSALEM, Pa., Oct. 7, 2020 /PRNewswire/ — ­Law Offices of Howard G. Smith reminds investors of the upcoming November 24, 2020deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Golar LNG Limited (“Golar” or the “Company”) (NASDAQ: GLNG) securities between April 30, 2020 and September 24, 2020, inclusive (the “Class Period”).  

Investors suffering losses on their Golar investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to [email protected].

On September 24, 2020, media reported that the Chief Executive Officer (“CEO”) of Golar’s joint venture, Hygo Energy Transition Ltd. (“Hygo”), was involved in a bribery network investigated in Brazil’s Operation Car Wash.

On this news, Golar’s share price fell $3.28, or 32%, to close at $6.86 per share on

Read More